Scarica l'app Stockscreener
3.52
5.07%
0.17
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ABVC Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.35
Aprire:
$3.39
Volume 24 ore:
235.25K
Relative Volume:
0.56
Capitalizzazione di mercato:
$59.78M
Reddito:
$152.40K
Utile/perdita netta:
$-10.52M
Rapporto P/E:
-1.4119
EPS:
-2.4931
Flusso di cassa netto:
$-4.26M
1 W Prestazione:
+0.28%
1M Prestazione:
+91.30%
6M Prestazione:
+550.41%
1 anno Prestazione:
+326.15%
Intervallo 1D:
$3.35
$3.60
Intervallo di 1 settimana:
$3.28
$3.92
Portata 52W:
$0.40
$5.48
Abvc Biopharma Inc Stock (ABVC) Company Profile
Nome
Abvc Biopharma Inc
Settore
Industria
Telefono
510-668-0881
Indirizzo
44370 OLD WARM SPRINGS BLVD., FREMONT
Confronta ABVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
3.52 | 59.61M | 152.40K | -10.52M | -4.26M | -2.4931 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Abvc Biopharma Inc Borsa (ABVC) Ultime notizie
ABVC BioPharma Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com
What drives ABVC BioPharma Inc. stock priceAccelerated wealth expansion - PrintWeekIndia
What analysts say about ABVC BioPharma Inc. stockFree Consultation - PrintWeekIndia
What makes ABVC BioPharma Inc. stock attractive to long term investorsValue Pick Scanner - Newser
Is ABVC BioPharma Inc. stock a growth or value playSafe Entry High Exit Alerts - Newser
Is ABVC BioPharma Inc. a good long term investmentFree Technical Analysis Support - jammulinksnews.com
ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program - Yahoo Finance
What makes ABVC BioPharma Inc. stock price move sharplySteady Profit Stock Forecasts - Newser
Why ABVC BioPharma Inc. stock attracts strong analyst attentionDaily Gain Forecast - Newser
How ABVC BioPharma Inc. stock performs during market volatilityFree Exclusive Access to Stock Gurus - Newser
ABVC BioPharma Soars 16%—Is This the Breakout Biotech Investors Have Been Waiting For? - AInvest
ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships - Yahoo Finance
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology - StreetInsider
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment - Yahoo Finance
ABVC BioPharma's Affiliate OncoX Acquires Lycopenoid Platform to Strengthen Oncology Portfolio - citybuzz -
ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million - The Globe and Mail
ABVC BioPharma Shareholders Approve Key Proposals - TipRanks
ABVC BioPharma Announces Board Approval of Share Dividend Showing Confidence in Subsidiary Growth and Long-Term Shareholder Value - Yahoo Finance
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Up 40.0% in May - Defense World
3 Top Growth Stocks to Buy in the Second Half of 2025 - The Globe and Mail
ABVC BioPharma Files $100 Million Mixed Shelf - marketscreener.com
ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance - Yahoo Finance
ABVC BioPharma Secures Japanese Patent for Botanical Depression Treatment - citybuzz -
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504 - Yahoo Finance
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan - Yahoo Finance
ABVC BIOPHARMA, INC. SEC 10-Q Report - TradingView
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
UPDATE: ABVC BioPharma Announces 2024 Financial Results - Yahoo Finance
ABVC BioPharma Reports Strong Financial Growth - TipRanks
ABVC Biopharma Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements - marketscreener.com
ABVC BioPharma Announces 2024 Financial Results - Yahoo Finance
ABVC BIOPHARMA, INC. SEC 10-K Report - TradingView
Abvc Biopharma Inc Azioni (ABVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):